1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
- Exhibit 06: Executive Summary – Chart on Market Segmentation by Application
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 13: Market segments
- 3.4 Market outlook: Forecast for 2023-2028
- Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
- Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
- 4.1 Global low-concentration atropine market 2018 - 2022
- Exhibit 18: Historic Market Size – Data Table on global low-concentration atropine market 2018 - 2022 ($ million)
- 4.2 Type Segment Analysis 2018 - 2022
- Exhibit 19: Historic Market Size – Type Segment 2018 - 2022 ($ million)
- 4.3 Application Segment Analysis 2018 - 2022
- Exhibit 20: Historic Market Size – Application Segment 2018 - 2022 ($ million)
- 4.4 Geography Segment Analysis 2018 - 2022
- Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ million)
- 4.5 Country Segment Analysis 2018 - 2022
- Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
- 5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
- 5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
- 5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
- 5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
- 5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
- 5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
- 5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Type
- 6.1 Market segments
- Exhibit 30: Chart on Type - Market share 2023-2028 (%)
- Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
- 6.2 Comparison by Type
- Exhibit 32: Chart on Comparison by Type
- Exhibit 33: Data Table on Comparison by Type
- 6.3 Atropine sulfate 0.01 percentage - Market size and forecast 2023-2028
- Exhibit 34: Chart on Atropine sulfate 0.01 percentage - Market size and forecast 2023-2028 ($ million)
- Exhibit 35: Data Table on Atropine sulfate 0.01 percentage - Market size and forecast 2023-2028 ($ million)
- Exhibit 36: Chart on Atropine sulfate 0.01 percentage - Year-over-year growth 2023-2028 (%)
- Exhibit 37: Data Table on Atropine sulfate 0.01 percentage - Year-over-year growth 2023-2028 (%)
- 6.4 Atropine sulfate 0.025 percentage - Market size and forecast 2023-2028
- Exhibit 38: Chart on Atropine sulfate 0.025 percentage - Market size and forecast 2023-2028 ($ million)
- Exhibit 39: Data Table on Atropine sulfate 0.025 percentage - Market size and forecast 2023-2028 ($ million)
- Exhibit 40: Chart on Atropine sulfate 0.025 percentage - Year-over-year growth 2023-2028 (%)
- Exhibit 41: Data Table on Atropine sulfate 0.025 percentage - Year-over-year growth 2023-2028 (%)
- 6.5 Atropine sulfate 0.05 percentage - Market size and forecast 2023-2028
- Exhibit 42: Chart on Atropine sulfate 0.05 percentage - Market size and forecast 2023-2028 ($ million)
- Exhibit 43: Data Table on Atropine sulfate 0.05 percentage - Market size and forecast 2023-2028 ($ million)
- Exhibit 44: Chart on Atropine sulfate 0.05 percentage - Year-over-year growth 2023-2028 (%)
- Exhibit 45: Data Table on Atropine sulfate 0.05 percentage - Year-over-year growth 2023-2028 (%)
- 6.6 Market opportunity by Type
- Exhibit 46: Market opportunity by Type ($ million)
- Exhibit 47: Data Table on Market opportunity by Type ($ million)
7 Market Segmentation by Application
- 7.1 Market segments
- Exhibit 48: Chart on Application - Market share 2023-2028 (%)
- Exhibit 49: Data Table on Application - Market share 2023-2028 (%)
- 7.2 Comparison by Application
- Exhibit 50: Chart on Comparison by Application
- Exhibit 51: Data Table on Comparison by Application
- 7.3 Child - Market size and forecast 2023-2028
- Exhibit 52: Chart on Child - Market size and forecast 2023-2028 ($ million)
- Exhibit 53: Data Table on Child - Market size and forecast 2023-2028 ($ million)
- Exhibit 54: Chart on Child - Year-over-year growth 2023-2028 (%)
- Exhibit 55: Data Table on Child - Year-over-year growth 2023-2028 (%)
- 7.4 Adult - Market size and forecast 2023-2028
- Exhibit 56: Chart on Adult - Market size and forecast 2023-2028 ($ million)
- Exhibit 57: Data Table on Adult - Market size and forecast 2023-2028 ($ million)
- Exhibit 58: Chart on Adult - Year-over-year growth 2023-2028 (%)
- Exhibit 59: Data Table on Adult - Year-over-year growth 2023-2028 (%)
- 7.5 Market opportunity by Application
- Exhibit 60: Market opportunity by Application ($ million)
- Exhibit 61: Data Table on Market opportunity by Application ($ million)
8 Customer Landscape
- 8.1 Customer landscape overview
- Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
- 9.1 Geographic segmentation
- Exhibit 63: Chart on Market share by geography 2023-2028 (%)
- Exhibit 64: Data Table on Market share by geography 2023-2028 (%)
- 9.2 Geographic comparison
- Exhibit 65: Chart on Geographic comparison
- Exhibit 66: Data Table on Geographic comparison
- 9.3 Asia - Market size and forecast 2023-2028
- Exhibit 67: Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Exhibit 68: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Exhibit 69: Chart on Asia - Year-over-year growth 2023-2028 (%)
- Exhibit 70: Data Table on Asia - Year-over-year growth 2023-2028 (%)
- 9.4 North America - Market size and forecast 2023-2028
- Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ million)
- Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
- Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
- 9.5 Europe - Market size and forecast 2023-2028
- Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
- Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
- 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- 9.7 US - Market size and forecast 2023-2028
- Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million)
- Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
- Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
- Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
- 9.8 China - Market size and forecast 2023-2028
- Exhibit 87: Chart on China - Market size and forecast 2023-2028 ($ million)
- Exhibit 88: Data Table on China - Market size and forecast 2023-2028 ($ million)
- Exhibit 89: Chart on China - Year-over-year growth 2023-2028 (%)
- Exhibit 90: Data Table on China - Year-over-year growth 2023-2028 (%)
- 9.9 Germany - Market size and forecast 2023-2028
- Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
- Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
- 9.10 Canada - Market size and forecast 2023-2028
- Exhibit 95: Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Exhibit 96: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Exhibit 97: Chart on Canada - Year-over-year growth 2023-2028 (%)
- Exhibit 98: Data Table on Canada - Year-over-year growth 2023-2028 (%)
- 9.11 Japan - Market size and forecast 2023-2028
- Exhibit 99: Chart on Japan - Market size and forecast 2023-2028 ($ million)
- Exhibit 100: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
- Exhibit 101: Chart on Japan - Year-over-year growth 2023-2028 (%)
- Exhibit 102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
- 9.12 Market opportunity by geography
- Exhibit 103: Market opportunity by geography ($ million)
- Exhibit 104: Data Tables on Market opportunity by geography ($ million)
10 Drivers, Challenges, and Trends
- 10.3 Impact of drivers and challenges
- Exhibit 105: Impact of drivers and challenges in 2023 and 2028
11 Vendor Landscape
- 11.2 Vendor landscape
- Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
- 11.3 Landscape disruption
- Exhibit 107: Overview on factors of disruption
- 11.4 Industry risks
- Exhibit 108: Impact of key risks on business
12 Vendor Analysis
- 12.1 Vendors covered
- Exhibit 109: Vendors covered
- 12.2 Market positioning of vendors
- Exhibit 110: Matrix on vendor position and classification
- 12.3 AdvaCare Pharma
- Exhibit 111: AdvaCare Pharma - Overview
- Exhibit 112: AdvaCare Pharma - Product / Service
- Exhibit 113: AdvaCare Pharma - Key offerings
- 12.4 Bausch Lomb Corp.
- Exhibit 114: Bausch Lomb Corp. - Overview
- Exhibit 115: Bausch Lomb Corp. - Business segments
- Exhibit 116: Bausch Lomb Corp. - Key news
- Exhibit 117: Bausch Lomb Corp. - Key offerings
- Exhibit 118: Bausch Lomb Corp. - Segment focus
- 12.5 ENTOD INTERNATIONAL
- Exhibit 119: ENTOD INTERNATIONAL - Overview
- Exhibit 120: ENTOD INTERNATIONAL - Key offerings
- 12.6 Eyenovia Inc.
- Exhibit 121: Eyenovia Inc. - Overview
- Exhibit 122: Eyenovia Inc. - Key offerings
- 12.7 Gmt Pharma
- Exhibit 123: Gmt Pharma - Overview
- Exhibit 124: Gmt Pharma - Product / Service
- Exhibit 125: Gmt Pharma - Key offerings
- 12.8 ISKON REMEDIES and GMT
- Exhibit 126: ISKON REMEDIES and GMT - Overview
- Exhibit 127: ISKON REMEDIES and GMT - Product / Service
- Exhibit 128: ISKON REMEDIES and GMT - Key offerings
- 12.9 Jawa Pharmaceuticals INDIA Pvt. Ltd.
- Exhibit 129: Jawa Pharmaceuticals INDIA Pvt. Ltd. - Overview
- Exhibit 130: Jawa Pharmaceuticals INDIA Pvt. Ltd. - Product / Service
- Exhibit 131: Jawa Pharmaceuticals INDIA Pvt. Ltd. - Key offerings
- 12.10 Medizia Biotech
- Exhibit 132: Medizia Biotech - Overview
- Exhibit 133: Medizia Biotech - Product / Service
- Exhibit 134: Medizia Biotech - Key offerings
- 12.11 OSRX Inc.
- Exhibit 135: OSRX Inc. - Overview
- Exhibit 136: OSRX Inc. - Product / Service
- Exhibit 137: OSRX Inc. - Key offerings
- 12.12 Raymed Pharmaceutical Ltd.
- Exhibit 138: Raymed Pharmaceutical Ltd. - Overview
- Exhibit 139: Raymed Pharmaceutical Ltd. - Product / Service
- Exhibit 140: Raymed Pharmaceutical Ltd. - Key offerings
- 12.13 Santen Pharmaceutical Co. Ltd.
- Exhibit 141: Santen Pharmaceutical Co. Ltd. - Overview
- Exhibit 142: Santen Pharmaceutical Co. Ltd. - Product / Service
- Exhibit 143: Santen Pharmaceutical Co. Ltd. - Key offerings
- 12.14 Sydnexis Inc.
- Exhibit 144: Sydnexis Inc. - Overview
- Exhibit 145: Sydnexis Inc. - Product / Service
- Exhibit 146: Sydnexis Inc. - Key offerings
- 12.15 Tache Pharmacy
- Exhibit 147: Tache Pharmacy - Overview
- Exhibit 148: Tache Pharmacy - Product / Service
- Exhibit 149: Tache Pharmacy - Key offerings
- 12.16 Taiwan Biotech Co.,Ltd
- Exhibit 150: Taiwan Biotech Co.,Ltd - Overview
- Exhibit 151: Taiwan Biotech Co.,Ltd - Product / Service
- Exhibit 152: Taiwan Biotech Co.,Ltd - Key offerings
- 12.17 Vyluma
- Exhibit 153: Vyluma - Overview
- Exhibit 154: Vyluma - Product / Service
- Exhibit 155: Vyluma - Key offerings
13 Appendix
- 13.2 Inclusions and exclusions checklist
- Exhibit 156: Inclusions checklist
- Exhibit 157: Exclusions checklist
- 13.3 Currency conversion rates for US$
- Exhibit 158: Currency conversion rates for US$
- 13.4 Research methodology
- Exhibit 159: Research methodology
- Exhibit 160: Validation techniques employed for market sizing
- Exhibit 161: Information sources
- 13.5 List of abbreviations
- Exhibit 162: List of abbreviations
Get the report (PDF) sent to your email within minutes.